Cargando…
Prostaglandin E-Major Urinary Metabolite Predicts Relapse in Patients With Ulcerative Colitis in Clinical Remission
INTRODUCTION: Prostaglandin E-major urinary metabolite (PGE-MUM) is a novel biomarker reflecting endoscopic activity in ulcerative colitis (UC). However, there are no studies investigating the efficacy of PGE-MUM as a biomarker for predicting relapse. We investigated whether PGE-MUM can predict clin...
Autores principales: | Ishida, Natsuki, Sugiura, Kiichi, Miyazu, Takahiro, Tamura, Satoshi, Suzuki, Satoshi, Tani, Shinya, Yamade, Mihoko, Iwaizumi, Moriya, Hamaya, Yasushi, Osawa, Satoshi, Furuta, Takahisa, Sugimoto, Ken |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7732263/ https://www.ncbi.nlm.nih.gov/pubmed/33512810 http://dx.doi.org/10.14309/ctg.0000000000000289 |
Ejemplares similares
-
Predicting Ulcerative Colitis Relapse in Clinical Remission With Fecal Immunochemical Occult Blood Test or Prostaglandin E-Major Urinary Metabolite
por: Ishida, Natsuki, et al.
Publicado: (2022) -
Comparison between Prostaglandin E-major urinary metabolite and C-reactive protein levels to reflect endoscopic scores in patients with ulcerative colitis
por: Ishida, Natsuki, et al.
Publicado: (2021) -
Real-World Efficacy and Safety Monitoring for Predicting Continuation of Tofacitinib Therapy in Patients with Ulcerative Colitis
por: Ishida, Natsuki, et al.
Publicado: (2021) -
Early serum albumin changes in patients with ulcerative colitis treated with tacrolimus will predict clinical outcome
por: Ishida, Natsuki, et al.
Publicado: (2021) -
Prostaglandin E-major urinary metabolite versus fecal immunochemical occult blood test as a biomarker for patient with ulcerative colitis
por: Ishida, Natsuki, et al.
Publicado: (2020)